The landscape of genetic medicine is constantly evolving, and a pivotal moment arrived in early 2024 when discussions over a novel approach to CRISPR technology began over slices of pizza. This wasn’t just a casual conversation; it was the genesis of a new company poised to tackle some of the most challenging genetic diseases.
during a spring gathering at berkeley’s Pizzeria da Laura, gene editing researcher Fyodor Urnov and venture capitalist Johnny Hu initiated plans for a unique CRISPR-focused enterprise. Urnov, a professor at the university of California, Berkeley, had consistently advocated for the potential of CRISPR to address ultra-rare genetic mutations, emphasizing the need for both regulatory support and dedicated company investment.Hu, possessing a ph.D. in gene editing and currently a principal at Menlo Ventures, shared this vision and sought to translate it into reality.
“johnny asked me a question I won’t soon forget: ‘how realistic is any of this?'” urnov remembers. “I responded by stating that the technological feasibility was established, but the real challenge lay in building a company capable of achieving success.”
The Rise of Targeted Gene Editing: A New Era in CRISPR Applications
For years, CRISPR-Cas9 has been heralded as a revolutionary gene editing tool, but its primary mechanism - cutting DNA – carries inherent risks. recent advancements, however, are shifting the paradigm. Scientists are now demonstrating the ability to activate genes without inducing these cuts, offering a potentially safer and more precise approach to treating genetic disorders. This new frontier focuses on epigenetic modifications, essentially altering gene expression rather than the underlying DNA sequence.
I’ve found that understanding the nuances of gene expression is crucial for developing effective therapies. It’s not always about changing the genetic code itself; sometimes, it’s about controlling how that code is read and utilized by the cell. This is where the latest CRISPR breakthroughs are proving notably promising.
Did you know? Epigenetics refers to changes in gene expression that do not involve alterations to the underlying DNA sequence, but rather to how the DNA is packaged and accessed.
Addressing Ultra-Rare mutations: A Growing Need
the focus on
